These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

838 related items for PubMed ID: 18971539

  • 1. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
    Eto H, Miyata M, Shirasawa T, Akasaki Y, Hamada N, Nagaki A, Orihara K, Biro S, Tei C.
    Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539
    [Abstract] [Full Text] [Related]

  • 2. Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis.
    Koga J, Egashira K, Matoba T, Kubo M, Ihara Y, Iwai M, Horiuchi M, Sunagawa K.
    Hypertens Res; 2008 Sep; 31(9):1791-800. PubMed ID: 18971558
    [Abstract] [Full Text] [Related]

  • 3. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.
    Iwai M, Chen R, Li Z, Shiuchi T, Suzuki J, Ide A, Tsuda M, Okumura M, Min LJ, Mogi M, Horiuchi M.
    Circulation; 2005 Sep 13; 112(11):1636-43. PubMed ID: 16145000
    [Abstract] [Full Text] [Related]

  • 4. Stimulation of the AT2 receptor reduced atherogenesis in ApoE(-/-)/AT1A(-/-) double knock out mice.
    Tiyerili V, Mueller CF, Becher UM, Czech T, van Eickels M, Daiber A, Nickenig G, Wassmann S.
    J Mol Cell Cardiol; 2012 Mar 13; 52(3):630-7. PubMed ID: 22230040
    [Abstract] [Full Text] [Related]

  • 5. Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor.
    Daugherty A, Rateri DL, Lu H, Inagami T, Cassis LA.
    Circulation; 2004 Dec 21; 110(25):3849-57. PubMed ID: 15596561
    [Abstract] [Full Text] [Related]

  • 6. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N, D'Orleans-Juste P, Kiss RS, You Z, Genest J, Al-Ramli W, Qureshi ST, Gramolini A, Behm D, Ohlstein EH, Harrison SM, Douglas SA, Giaid A.
    Circ Res; 2009 Sep 25; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [Abstract] [Full Text] [Related]

  • 7. LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet.
    Hu C, Dandapat A, Sun L, Chen J, Marwali MR, Romeo F, Sawamura T, Mehta JL.
    Cardiovasc Res; 2008 Jul 15; 79(2):287-93. PubMed ID: 18453637
    [Abstract] [Full Text] [Related]

  • 8. Decreased levels of lipid peroxidation-induced DNA damage in the onset of atherogenesis in apolipoprotein E deficient mice.
    Godschalk RW, Albrecht C, Curfs DM, Schins RP, Bartsch H, van Schooten FJ, Nair J.
    Mutat Res; 2007 Aug 01; 621(1-2):87-94. PubMed ID: 17418875
    [Abstract] [Full Text] [Related]

  • 9. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet.
    Harrington SC, Simari RD, Conover CA.
    Circ Res; 2007 Jun 22; 100(12):1696-702. PubMed ID: 17510462
    [Abstract] [Full Text] [Related]

  • 10. Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse.
    Thomas MC, Pickering RJ, Tsorotes D, Koitka A, Sheehy K, Bernardi S, Toffoli B, Nguyen-Huu TP, Head GA, Fu Y, Chin-Dusting J, Cooper ME, Tikellis C.
    Circ Res; 2010 Oct 01; 107(7):888-97. PubMed ID: 20671240
    [Abstract] [Full Text] [Related]

  • 11. Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice.
    Miyoshi T, Li Y, Shih DM, Wang X, Laubach VE, Matsumoto AH, Helm GA, Lusis AJ, Shi W.
    Life Sci; 2006 Jul 04; 79(6):525-31. PubMed ID: 16516241
    [Abstract] [Full Text] [Related]

  • 12. Endothelial overexpression of Fas ligand decreases atherosclerosis in apolipoprotein E-deficient mice.
    Yang J, Sato K, Aprahamian T, Brown NJ, Hutcheson J, Bialik A, Perlman H, Walsh K.
    Arterioscler Thromb Vasc Biol; 2004 Aug 04; 24(8):1466-73. PubMed ID: 15178561
    [Abstract] [Full Text] [Related]

  • 13. Total panax notoginsenosides prevent atherosclerosis in apolipoprotein E-knockout mice: Role of downregulation of CD40 and MMP-9 expression.
    Liu G, Wang B, Zhang J, Jiang H, Liu F.
    J Ethnopharmacol; 2009 Nov 12; 126(2):350-4. PubMed ID: 19703533
    [Abstract] [Full Text] [Related]

  • 14. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S, Higashi Y, Shai SY, Vaughn C, Mohler J, Li Y, Song YH, Titterington J, Delafontaine P.
    Arterioscler Thromb Vasc Biol; 2007 Dec 12; 27(12):2684-90. PubMed ID: 17916769
    [Abstract] [Full Text] [Related]

  • 15. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
    Oumouna-Benachour K, Hans CP, Suzuki Y, Naura A, Datta R, Belmadani S, Fallon K, Woods C, Boulares AH.
    Circulation; 2007 May 08; 115(18):2442-50. PubMed ID: 17438151
    [Abstract] [Full Text] [Related]

  • 16. Tanshinone II-A attenuates and stabilizes atherosclerotic plaques in apolipoprotein-E knockout mice fed a high cholesterol diet.
    Xu S, Little PJ, Lan T, Huang Y, Le K, Wu X, Shen X, Huang H, Cai Y, Tang F, Wang H, Liu P.
    Arch Biochem Biophys; 2011 Nov 08; 515(1-2):72-9. PubMed ID: 21889487
    [Abstract] [Full Text] [Related]

  • 17. Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth.
    Luttun A, Lutgens E, Manderveld A, Maris K, Collen D, Carmeliet P, Moons L.
    Circulation; 2004 Mar 23; 109(11):1408-14. PubMed ID: 14993123
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution.
    Sales VL, Sukhova GK, Lopez-Ilasaca MA, Libby P, Dzau VJ, Pratt RE.
    Circulation; 2005 Nov 22; 112(21):3328-36. PubMed ID: 16286588
    [Abstract] [Full Text] [Related]

  • 19. Endothelial nitric oxide deficiency reduces MMP-13-mediated cleavage of ICAM-1 in vascular endothelium: a role in atherosclerosis.
    Tarín C, Gomez M, Calvo E, López JA, Zaragoza C.
    Arterioscler Thromb Vasc Biol; 2009 Jan 22; 29(1):27-32. PubMed ID: 18988893
    [Abstract] [Full Text] [Related]

  • 20. Effect of MMP-2 deficiency on atherosclerotic lesion formation in apoE-deficient mice.
    Kuzuya M, Nakamura K, Sasaki T, Cheng XW, Itohara S, Iguchi A.
    Arterioscler Thromb Vasc Biol; 2006 May 22; 26(5):1120-5. PubMed ID: 16556856
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.